Lactoferrin: Natural - multifunctional - antimicrobial

Lactoferrin: Natural - Multifunctional - Antimicrobial

Volumn , Issue , 2000, Pages 1-87

  Naidu, A S ^a  

^a CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL AGENTS; FOOD PROCESSING; MICROORGANISMS;

BLOCKING AGENTS; FOOD PROCESSING TECHNOLOGY; FOOD SAFES; FOOD SURFACES; FOOD-BORNE PATHOGENS; LACTOFERRIN; NATURALLY OCCURRING;

FOOD MICROBIOLOGY;

EID: 0011830076     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (379)

1. Abramson, J.S., Parce, J.W., Lewis, J.C., Lyles, D.S., Mills, EL., Nelson, R.D., and Bass, D.A. 1984. Characterization of the effect of influenza vims on polymorphonuclear leukocyte membrane responses. Blood 64: 131-138.
2. Aguas, A., Esaguy, N., Sunkel, C.E., and Silva, M.T. 1990. Cross reactivity and sequence homology between the 65-kilodalton mycobacterial heat shock protein and human lactoferrin, transferrin, and DR beta subsets of major histocompatibility complex class II molecules. Infect. Immun. 58: 1461-1470.
3. Ahmadzadeh, N., Shingu, M., and Nobunaga, M. 1989. Iron-binding proteins and free iron in synovial fluids of rheumatoid arthritis patients. Clin. Immunol. 8: 345-351.
4. Ainscough, E.W., Brodie, A.M., Plowman, J.E., Bloor, S.J., Loehr, J.S., and Loehr, T.M. 1980. Studies on human lactoferrin by electron paramagnetic resonance, fluorescence, and resonance Raman spectroscopy. Biochemistry 19: 4072-4079.
5. Aisen, P., and Leibman, A. 1972. Lactoferrin and transferrin: A comparative study. Biochim. Biophys. Acta 257: 314-323.
6. Al-Mashikhi, S.A., and Nakai, S. 1987. Isolation of bovine immunoglobulins and lactoferrin from whey proteins by gel filtration techniques. J. Dairy Set 70: 2486-2492.
7. Alugupalli, K.R., Kalfas, S., Edwardsson, S., Forsgren, A., Arnold, R.R., and Naidu, A.S. 1994. Effect of lactoferrin on interaction of Prevotella intermedia with plasma and subepithelial matrix proteins. Oral Microbiol. Immunol. 9: 174-179.
8. Alugupalli, K.R., and Kalfas, S. 1995. Inhibitory effect of lactoferrin on the adhesion of Actinobacillus actinomycetemcomitans and Prevotella intermedia to fibroblasts and epithelial cells. APMIS 103: 154-160.
9. Alugupalli, K.R., Kalfas, S., Edwardsson, S., and Naidu, A.S. 1995. Lactoferrin interaction with Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 10: 35-41.
10. Alugupalli, K.R., and Kalfas, S. 1997. Characterization of the lactoferrin-dependent inhibition of the adhesion of Actinobacillus actinomycetemcomitans, Prevotella intermedia and Prevotella nigrescens to fibroblasts and to a reconstituted basement membrane. APMIS 105: 680-688.
11. Ambruso, D.R., Sasada, M., Nishiyama, H., Kubo, A., Komiyama, A., and Allen, R.H. 1984. Defective bactericidal activity and absence of specific granules in neutrophils from a patient with recurrent bacterial infections. J. Clin. Immunol. 4: 23-30.
12. Amini, H.R., Ascencio, F., Ruiz-Bustos, E., Romero, M.J., and Wadstrom, T. 1996. Cryptic domains of a 60 kDa heat shock protein of Helicobacter pylori bound to bovine lactoferrin. FEMS Immunol. Med. Microbiol. 16: 247-55.
13. Andersson, B.F., Baker, H.M, Dodson, E.J., Norris, G.E., Rumball, S.V., Waters, J.M, and Baker E.N. 1987. Structure of human lactoferrin at 3.2-Å resolution. Proc. Natl. Acad. Sci. USA. 84: 1769-1773.
14. Anderson, B.F., Baker, H.M., Norris, G.E., Rice, D.W., and Baker, E.N. 1989. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol. 209: 711-734.
15. Appelmelk, BJ., An, Y.Q., Geerts, M., Thijs, B.G., de Boer. H.A., MacLaren, D.M., de Graaff, J., and Nuijens, J.H. 1994. Lactoferrin is a lipid A-bmding protein. Infect. Immun. 62: 2628-2632.
16. Arnold, R.R., Cole, M.F., and McGhee, J.R. 1977. A bactericidal effect for human lactoferrin. Science 197: 263-265.
17. Arnold, R.R., Brewer, M., and Gauthier, J.J. 1980. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 28: 893-898.
18. Arnold, R.R., Russell, J.E., Champion, W.J., and Gauthier, J.J. 1981. Bactericidal activity of human lactoferrin: influence of physical conditions and metabolic state of the target microorganism. Infect. Immun. 32: 655-660.
19. Ascencio, F., Ljungh, A., and Wadstrom, T. 1992. Lactoferrin binding properties of Vibrio cholerae. Microbios. 70: 103-117.
20. Ashom, R.G., Eskola, J., Tuohimaa, P.J., and Krohn, K.J. 1986. Effect of progesterone-inducible proteins human lactoferrin and avidin on lymphocyte proliferation. Human Reproduct. 1: 149-151.
21. Aslam, M., and Hurley, W.L. 1997. Proteolysis of milk proteins during involution of the bovine mammary gland. J. Dairy Sci. 80: 2004-2010.
22. Azari, P., and Baugh, R.F. 1967. A simple and rapid procedure for preparation of large quantities of pure ovotransferrin. Arch. Biochem. Biophys. 118: 138-145.
23. Baggiolini, M., De Duve, C, Masson, P.L., and Heremans, J.F. 1970. Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J. Exp. Med. 131: 559-570.
24. Baker, E.N., Rumball, S.V., and Andersson, B.F. 1987. Transferrins: insight into structure and function from studies on lactoferrin. Trends Biochem. Sci. 12: 350-353.
25. Baker, E.N., Anderson, B.F., Baker, H.M., Haridas, M., Jameson, G.B., Norris, G.E., RumbaU, S.V., and Smith, C.A. 1991. Structure, function and flexibility of human lactoferrin. Int. J. Biol. Macromol. 13: 122-129.
26. Balmer, S.E., Scott, P.H., and Wharton, B.A. 1989. Diet and feacal flora in the newborn: lactoferrin. Arch Dis Child. 64: 1685-1690.
27. Barresi, G., and Tuccari, G. 1987. Iron-binding proteins in thyroid tumours: an immunocytochemical study. Pathol. Res. Pract. 182: 344-351.
28. Barthe, C, Galabert, C, Guy-Crotte, O., and Figarella, C. 1989. Plasma and serum lactoferrin levels in cystic fibrosis. Relationship with the presence of cystic fibrosis protein. Clin. Chim. Acta 181: 183-188.
29. Batish, V.K., Chander, H., Zumdegni, K.C., Bhatia, K.L., and Singh, R.S. 1988. Antibacterial effect of lactoferrin against some common food-borne pathogenic organisms. Austral. J. Dairy Technol. 5: 16-18.
30. Baynes, R.D., Bezwoda, W.R., and Mansoor. N. 1988. Neutrophil lactoferrin content in viral infections. Am. J. Clin. Pathol. 89: 225-228.
31. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M. 1992. Identification of tire bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121: 130-136.
32. Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., and Tomita, M. 1993. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. (Berl) 182: 97-105.
33. Bennett, R.M., and Kokocinski, T. 1978. Lactoferrin content of peripheral blood cells. Br. J. Haematol. 39: 509-521.
34. Bennett, R.M., and Mohla, C. 1976. A solid phase radioimmunoassay for the measurement of lactoferrin in human plasma: variation with age, sex and disease. J. Lab. Clin. Med. 88: 156-166.
35. Bennett, R.M., and Skosey, J.L. 1977. Lactoferrin and lysozyme levels in synovial fluid: differential indices of articular inflammation and degradation. Arthrit. Rheumat. 20: 84-90.
36. Bennett, R.M., and Kokocinski, T. 1979. Lactoferrin turnover in man. Clin. Sci. 57: 453-460.
37. Bennett, R.M., Bagby, G.C., and Davis, J. 1981. Calcium-dependent polymerization of lactoferrin. Biochem. Biophys. Res. Commun. 101: 88-95.
38. Bennett, R.M., and Davis, J. 1982. Lactoferrin interacts with deoxyribonucleic acid: a preferential reactivity with double-stranded DNA and dissociation of DNA-anti-DNA complexes. J. Lab. Clin. Med. 99: 127-38.
39. Bennett, R.M., Davis, J., Campbell, S., and Portnoff, S. 1983. Lactoferrin binds to cell membrane DNA. Association of surface DNA with an enriched population of B cells and monocytes. J. Clin. Invest. 71: 611-618.
40. Bennett, R.M., Merritt, M.M., and Gabor, G. 1986. Lactoferrin binds to neutrophilic membrane DNA. Br. J. Haematol. 63: 105-117.
41. Bezwoda, W.R., and Mansoor, H. 1986. Isolation and characterization of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbent. Clin. Chim. Acta 157: 89-95.
42. Bezwoda, W.R., and Mansoor, N. 1989. Lactoferrin from human breast milk and from neutrophil granulocytes. Comparative studies of isolation, quantitation, characterization and iron binding properties. Biomed. Chromat. 3: 121-126.
43. Bhimani, R.S., Vendrov, Y., and Furmanski, P. 1999. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J. Appl. Microbiol. 86: 135-144.
44. Birgens, H.S., and Kristensen, L. O. 1990. Impaired receptor binding and decrease in isoelectric point of lactoferrin after interaction with human monocytes. Eur. J. Haemat 45: 31-35.
45. Bishop, J.G., Schanbacher, F.L., Ferguson, L.C., and Smith, K.L. 1976. In vitro growth inhibition of mastitis-causing conform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo lactoferrin. Infect. Immun. 14: 911-918.
46. Biswas, G.B., and Sparling, P.F. 1995. Characterization of IbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect. Immun. 63: 2958-2967.
47. Blackberg, L., and Hemell, O. 1980. Isolation of lactoferrin from human whey by a single chromatography step. FEES Letts. 109: 180-184.
48. Blake, D.R., Hall, N.D., Bacon, P.A. 1981. The importance of iron in rheumatoid disease. Lancet 21: 1142-1143.
49. Blake, D.R., Gallagher, P.J., and Potter, A.R. 1984. The effect of synovial iron on the progression of rheumatoid disease. Arthritis Rheum. 27: 495-501.
50. Blanc, B., and Isliker, H.C. 1961a. Isolement et caracterisation de la proteine rouge siderophile dulait maternel: la lactoferrine. Helv. Physiol. Pharmacol. Acta 19: C-13-14.
51. Blanc, B., and Isliker, H.C. 1961b. Isolement et caracterisation de la proteine rouge siderophile dulait maternel: la lactoferrine. Bull. Soc. Chim. Biol (Paris) 43: 929-943.
52. Bortner, C.A., Miller, R.D., and Arnold, R.R. 1986. Bactericidal effect of lactoferrin on Legionella pneumophila. Infect. Immun. 51: 373-377.
53. Bortner, C.A., Arnold, R.R., and Miller, R.D. 1989. Bactericidal effect of lactoferrin on Legionella pneumophila: effect of the physiological state of the organism. Can. J. Microbiol. 35: 1048-1051.
54. Boxer, L.A., Bjorksten, B., Bjork, J., Yang, H.H., Alen, J.M., and Baehner, R.L. 1982a. Neutropenia induced by systemic infusion of lactoferrin. J. Lab. Clin. Med. 99: 866-872.
55. Boxer, L.A., Haak, R.A., Yang, H.H., Wolach, J.B., Whitcomb, J.A., Buttenck, C.J., and Baehner, R.L. 1982b. Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes. J. Clin. Invest. 70: 1049-1057.
56. Breau, W.C., and Oliver, S.P. 1986. Growth inhibition of environmental mastitis pathogens during physiologic transitions of the bovine mammary gland. Am. J. Vet. Res. 47: 218-222.
57. Brines, R.D., and Brock, J.H. 1983. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim. Biophys. Acta 759: 229-235.
58. Britigan, B.E., Hayek, M.B., Doebbeling, B.N., and Fick, R.B. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeinginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61: 5049-5055.
59. Britigan, B.E., Serody, J.S., and Cohen, M.S. 1994. The role of lactoferrin as an anti-inflammatory molecule. Adv. Exp. Med. Biol. 357:143-156.
60. Brock, J.H., Arzabe, F., Lampreave, F, and Pineiro, A. 1976. The effect of trypsin on bovine transferrin and lactoferrin. Biochim. Biophys. Acta 446: 214-225.
61. Brock, J.H., Pineiro, A., and Lampreave, F. 1978. The effect of trypsin and chymotrypsin on the antibacterial activity of complement, antibodies, and lactoferrin and transferrin in bovine colostrum. Ann. Reck Vet. 9: 287-294.
62. Brock, J.H., Pickering, M.G., McDowall, M.C., and Deacon, A.G. 1983. Role of antibody and enterobactin in controlling growth of Escherichia colt in human milk and acquisition of lactoferrin-and transferrin-bound iron by Escherichia coli. Infect. Immun. 40: 453-459.
63. Brodie, A.M., Ainscough, E.W., Baker, E.N., Baker, H.M., Shongwe, M.S., and Smith, C.A. 1994. Synergism and substitution in the lactoferrins. Adv. Exp. Med. Biol. 357: 33-44.
64. Broer, K.H., Dauber, U., Herrmann, W.P., and Hirshhauser, C. 1977. The presence of lactoferrin (SCA) on the human sperm head during in vitro penetration through cervical mucus. IRCSJ. Med. Sci. 5: 362.
65. Broxmeyer, H.E., Smithyman, A., Eger, R.R., Meyers, P.A., and de Sousa, M. 1978. Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J. Exp. Med. 148: 1052-1067.
66. Broxmeyer, H.E., and Platzer, E. 1984. Lactoferrin acts on I-A and I-E/C antigen subpopulations of mouse peritoneal macrophages in tire absence of T lymphocytes and other cell types to inhibit production of granulocyte-monocyte colony stimulatory factors in vitro. J. Immunol. 133: 306-314.
67. Broxmeyer, H.E., Williams, D.E., Hangoc, G., Cooper, S., Gentile, P., Shen, R.N., Ralph, P., Gillis, S., and Bicknell, D.C. 1987. The opposing action in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors. Blood Cells 13: 31-48.
68. Bukhhardt, H., and. Schwingel, M. 1986. Oxygen radicals as effectors of cartilage destruction. Arthritis Rheum. 30: 57-63.
69. Bullen, J.J. 1975. Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad. Med. J. 51: 67-70.
70. Bullen, J.J. 1976. Iron-binding proteins and other factors in milk responsible for resistance to Escherichia coli. Ciba Found. Symp. 42: 149-169.
71. Bullen, J.J. 1981. The significance of iron in infection. Rev. Infect. Dis. 3: 1127-1138.
72. Burrin, D.G., Wang, H., Heath, J., and Dudley, M.A. 1996. Orally administered lactoferrin increases hepatic protein synthesis in formula-fed newborn pigs. Pediatr. Res. 40(1): 72-76.
73. Butler, J.E. 1973. The occurrence of immunoglobulin fragments, two types of lactoferrin and a lactoferrin-IgG2 complex in bovine colostral and milk whey. Biochim. Biophys. Acta 295: 341-351.
74. Byatt, J.C., Schmuke, J.J., Comens, P.G., Johnson, D.A., and Collier, R.J. 1990. The effect of bovine lactoferrin on muscle growth in-vivo and in-vitro. Biochem. Biophys. Res. Comm. 173: 548-553.
75. Byrd, T.F., and Horwitz, M.A. 1991. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J. Clin. Invest. 88: 1103-1112.
76. Campagnari, A.A., Shanks, K.L., and Dyer, D.W. 1994. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect. Immun. 62: 4909-4914.
77. Carlsson, A., Bjorck, L., and Persson, K. 1989. Lactoferrin and lysozyme in milk during acute mastitis and their inhibitory effect in Delvotest P. J. Dairy. Sci. 72: 3166-3175.
78. Carnoy, C, Scharfman, A., van Brussel, E., Lamblin, G., Ramphal, R., and Roussel, P. 1994. Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins. Infect. Immun. 62: 1896-1900.
79. Caselitz, J., Jaup, T., and Seifer, G. 1981. Lactoferrin and lysozyme in carcinomas of the parotid gland. Virchows Arch. A. 394: 61-73.
80. Castellino, F.J., Fish, W.W., and Mann, K.G. 1970. Structural studies on bovine lactoferrin. J. Biol. Chem. 245: 4269-4275.
81. Charpin, C, Lachard, A., and Pourreau-Schneider, N. 1985. Localization of lactoferrin and nonspecific cross-reacting antigen in human breast carcinomas. Cancer 55: 2612-2617.
82. Chierici, R, Sawatzki, G., Tamisari, L., Volpato, S., and Vigi, V. 1992. Supplementation of an adapted formula with bovine lactoferrin. 2. Effects on serum iron, ferritin and zinc levels. Acta Paediatr. 81: 475-479.
83. Chimura, T., Hirayama, T., Nakahara, M. 1993. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil. Jpn. J. Antibiot. 46: 482-485.
84. Cohen, M.S., Mao, J., Rasmussen, G.T., Serody, J.S., and Britigan, B.E. 1992. Interaction of lactoferrin and lipopolysaccharide (LPS): effects on the antioxidant property of lactoferrin and the ability of LPS to prime human neutrophils for enhanced superoxide formation. J. Infect. Dis. 166: 1375-1378.
85. Courtoy, P.J., Moguilevsky, N., Retegui, L.A., Castracane, C.E., and Masson, P.L. 1984. Uptake of lactoferrin by the liver. II. Endocytosis by sinusoidal cells. Lab. Invest. 50: 329-334.
86. Cox, T.M., Mazurier, J., Spik, G., Montreuil, J., and Peters, T.J. 1979. Iron-binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human small intestine. Biochim. Biophys. Acta 588: 120-128.
87. Cravito, A., Tello, A., Villafan, H., Ruiz, J., del Vedovo, S., and Neeser, J.R. 1991. Inhibition of localized adhesion of enteropathogenic Escherichia coli to Hep-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163: 1247-1255.
88. Crosa, J.H. 1989. Genetics and molecular biology of siderophore-mediated iron transport in bacteria. Microbiol. Rev. 53: 517-530.
89. Crouch, S.P.M., Slater, K.J., and Fletcher, J. 1992. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80: 235-240.
90. Culiiere, M.L., Montague, P., Mole, C, Bene, M.C., and Faure, G. 1997. Microparticle-enhanced nephlo-metric immunoassay of lactoferrin in human milk. J. Clin. Lab. Anal. 11: 239-243.
91. Custer, M.C., and Hansen, J.N. 1983. Lactoferrin and transferrin fragments react with nitrite to form an inhibitor of Bacillus cereus spore outgrowth. Appl. Environ. Microbiol. 45: 942-949.
92. Dalmastri, C, Valenti, P., Visca, P., Vittorioso, P., and Orsi, N. 1988. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica 11: 225-230.
93. Davidson, L.A., and Lonnerdal, B. 1986. Isolation and characterization of rhesus monkey lactoferrin. Pediatr. Res. 20: 197-201.
94. Davidson, L., and Lonnerdal, B. 1988. Specific binding of lactoferrin to brash border membrane: Ontogeny and effect of glycan chain. Am. J. Physiol. 257: 930-934.
95. Davidson, L.A., Litov, R.E., and Lonnerdal, B. 1990. Iron retention from lactoferrin-supplemented formulas in infant rhesus monkeys. Pediatr. Res. 27: 176-180.
96. Davidson, L., Kastenmayer, P., Yuen, M., Lonnerdal, B., and Hurrell, R.F. 1994. Influence of lactoferrin on iron absorption from human milk in infants. Pediatr. Res. 35: 117-124.
97. de Lillo, A., Teanpaisan, R., Fierro, J.F., and Douglas, C.W. 1996. Binding and degradation of lactoferrin by Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol. Med. Microbiol. 14: 135-143.
98. de Lillo, A., Quiros, L.M., and Fierro, J.F. 1997. Relationship between antibacterial activity and cell surface binding of lactoferrin in species of genus Micrococcus. FEMS Microbiol. Lett. 150: 89-94.
99. de Vet, B.J., and van Gool, J. 1974. Lactoferrin and iron absorption in the small intestine. Acta Med. Scand. 196: 393-402.
100. de Vet, B.J., and van Vugt, H. 1971. Lactoferrin, in particular the relation with iron absorption. Ned. Tijdschr. Geneeskd. 115: 961-967.
101. Debbabi, H., Dubarry, M., Rautureau, M., and Tome, D. 1998. Bovine lactoferrin induces both mucosal and systemic immune response in mice. J. Dairy Res. 65: 283-293.
102. Denisova, I.I., Gennadeva, T.I., Zhdanova, T.V., Khristova, M., and Khazenson, L.B. 1996. The action of lactoperoxidase, lactoferrin and lactoglobulin on Shigella sonnei in an in vivo experiment. Zh. Mikrobiol. Epidemiol. Immunobiol. 1: 66-69.
103. Dhaenens, L., Szczebara, F., and Husson, M.O. 1997. Identification, characterization, and immunogenici-ty of the lactoferrin-bmding protein from Helicobacter pylori. Infect. Immun. 65: 514-518.
104. Dial, E.J., Hall, L.R., Sema, H., Romero, J.J., Fox, J.G., and Lichtenberger, L.M. 1998. Antibiotic properties of bovine lactoferrin on Helicobacter pylori. Dig. Dis. Sci. 43: 2750-2756.
105. Dinarello, C.A. 1984. Interleukin-1. Rev. Infect. Dis. 6: 51-95.
106. Dionysius, D.A., and Milne, J.M. 1997. Antibacterial peptides of bovine lactoferrin: purification and characterization. J. Dairy Sci. 80: 667-674.
107. Dionysius, D.A., Grieve, P.A., and Milne, J.M. 1993. Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli. J. Dairy Sci. 76: 2597-2600.
108. Dite, P., Bartova, M., and Skaunic, V. 1989. Assessment of lactoferrin in the diagnosis of pancreatic disease. Ynitrni. Lek. 35: 132-136.
109. Dolby, J.M., Stephens, S., and Honour, P. 1977. Bacteriostasis of Escherichia coli by milk. II. Effect of bicarbonate and transferrin on the activity of infant feeds. J. Hyg. (Lond). 78: 235-242.
110. Dorland, L., Haverkamp, J., Vliegenthart, J.F.G., Spik, G., Fournet, B., and Montreuil, J. 1979. Investigation by 300-MHz lH-nuclear magnetic resonance spectroscopy and methylation analysis of the single glycan chain of chicken ovotransferrin. Eur. J. Biochem. 100: 569-574.
111. Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V, Motas, C, Montreuil, J., and Spik G. 1995. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312: 839-45.
112. Ellison, R.T., Giehl, T.J., and LaForce, F.M. 1988. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect. Immun. 56: 2774-2781.
113. Ellison, R.T., LaForce, F.M., Giehl, T.J., Boose, D.S., and Dunn, B.E. 1990. Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca:T and Mg2+. J. Gen. Microbiol. 136: 1437-1446.
114. Ellison, R.T., and Giehl, T.J. 1991. Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88: 1080-1091.
115. Erdei, J., Forsgren, A., and Naidu, A.S. 1994. Lactoferrin binds to porins OmpF and OmpC in. Escherichia coli. Infect. Immun. 62:1236-1240.
116. Faber, H.R., Bland, T., Day, C.L., Norns, G.E., Tweedie, J.W., and Baker, E.N. 1996. Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin. J. Mol. Biol. 256: 352-363.
117. Fairweather-Tait, S.J., Balmer, S.E., Scott, P.H., and Minski, MJ. 1987. Lactoferrin and iron absorption in newborn infants. Pediatr. Res. 22: 651-654.
118. Feng, M., van der Does, L., and Bantjes, A. 1995. Preparation of apolactoferrin with a very low iron saturation. J. Dairy Sei. 78: 2352-2357.
119. Foster, L.A., and Dyer, D.W. 1993. A siderophore production mutant of Bordetella bronchiseptica cannot use lactoferrin as an iron source. Infect. Immun. 61: 2698-2702.
120. Fransson, G.B., Keen, C.L., and Lonnerdal, B. 1983. Supplementation of milk with iron bound to lactoferrin using weanling mice: Effects on hematology and tissue iron. J. Pediatr. Gastroenterol. Nutr. 2: 693-700.
121. Friedman, S.A., Mandel, I.D., and Herrera, M.S. 1983. Lysozyme and lactoferrin quantitation in tire crevicular fluid. J. Periodontal. 54: 347-350.
122. Fujihara, T., and Hayashi, K. 1995. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol. 140: 1469-72.
123. Furmanski, P., Li, Z-P., Fortuna, M.B., Swamy, C.V.B., and Das, M.R. 1989. Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity. J. Exp. Med. 170: 415-429.
124. Gado, I., Erdei, J., Laszlo, V.G., Paszti, J., Czirok, E., Kontrohr, T., Toth, I., Forsgren, A., and Naidu, A.S. 1991. Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli. Antimicrob. Agents Chemother. 35: 2538-2543.
125. Gahr, M., Schulze, M., Schefeczyk, D., Speer, CP., and Peters, J.H. 1987. Diminished release of lactoferrin from polymorphonuclear leukocytes in human neonates. Acta Hematol. 77: 90-95.
126. Garre, C, Bianchi-Scarra, G., Sirito, M., Musso, M., and Ravazzolo, R. 1992. Lactoferrin binding sites and nuclear localization in K562(S) cells. J. Cell. Physiol. 153: 477-482.
127. Gatter, K.C., Brown, G., Trowbridge, LS., Woolston, R.E., and Mason, D.Y. 1983. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol 36:539-545.
128. Gillin, F.D., Reiner, D.S., and Wang, C.S. 1983. Killing of Giardia lamblia trophozoites by normal human milk. J. Cell Biochem. 23: 47-56.
129. Giugliano, L.G., Ribeiro, S.T., Vainstein, M.H., and Ulhoa, C.J. 1995. Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J. Med. Microbiol. 42: 3-9.
130. Godo, Z.I., Magyar, E., Andirko, I., and Rozgonyi, F. 1997. Compact growth of Staphylococcus haemolyti-cus in soft agar is not due to hydrophobic interaction between the cocci. Acta Microbiol. Immunol. Hung. 44: 343-349.
131. Görden, W.G., Groves, M.L., and Bäsch, J.J. 1963. Bovine milk ‘red protein’: amino acid composition and comparison with blood transferrin. Biochemistry 2: 817-820.
132. Griffiths, E., and Humphreys, J. 1977. Bacteriostatic effect of human milk and bovine colostrum on Escherichia coli: importance of bicarbonate. Infect. Immun. 15: 396-401.
133. Groenink, J., Walgreen-Weterings, E., van’t Hof, W., Veerman, E.C., and Nieuw Amerongen, A.V. 1999. Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol. Lett. 179: 217-222.
134. Grover, M., Giouzeppos, O., Schnagl, R.D., and May, J.T. 1997. Effect of human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus. Acta. Paediatr. 86: 315-316.
135. Groves, M. 1960. The isolation of a red protein from milk. J. Am. Chem. Soc. 82: 3345-3350.
136. Gruttner, R., Schafer, K.H., and Schroter, W. 1960. Zur remdarstellung eines eisenbindenden proteins in der frauenmilch. Klinische Wochenschrift 38: 1162-1165.
137. Gutteberg, T.J., Haneberg, B., and Jorgensen, T. 1984. The latency of serum acute phase proteins in meningococcal septicemia, with special emphasis on lactoferrin. Clin. Chim. Acta 136: 173-178.
138. Gutteberg, T.J., Røkke, O., Andersen, O., and Jorgensen, T. 1988. Lactoferrin as an indicator of septicemia and endotoxaemia in pigs. Scand. J. Infect. Dis. 20: 659-666.
139. Gutteberg, T.J., Røkke, O., Andersen, O., and Jorgensen, T. 1989. Early fall of circulating iron and rapid rise of lactoferrin in septicemia and endotoxemia: an early defence mechanism. Scand. J. Infect. Dis. 21: 709-715.
140. Gutteberg, T.J., Osterud, B., Volden, G., and Jorgensen, T. 1990a. The production of tumour necrosis factor, tissue thromboplastin, lactoferrin and cathepsin C during lipopolysaccharide stimulation in whole blood. Scand. J. Clin. Lab. Invest. 50: 421-427.
141. Gutteberg, T.J., Dalaker, K., and Vorland, L.H. 1990b. Early response in neonatal septicemia. The effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on the generation of lactoferrin. APMIS 98: 1027-1032.
142. Hamilton, H.L., and Czuprynski, C.J. 1992. Effects of mycobactin J and lactoferrin supplementation of drinking water on the in vivo multiplication of Mycobacterium paratuberculosis in gnotobiotic mice. Can J Yet Res. 56: 70-73.
143. Hammerschmidt, S., Bethe, G., Remane, P., and Chhatwal, G.S. 1999. Identification of pneumococcal surface protein A as a lactoferrin-bmdmg protein of Streptococcus pneumoniae. Infect. Immun. 67:1683-1687.
144. Hangoc, G., Lu, L., Oliff, A., Gillis, S., Hu, W., Bicknell, D.C., Williams, D., and Broxmeyer, H.E. 1987. Modulation of Friend virus infectivity in vivo by administration of purified preparations of human lactoferrin and recombinant murine interleukin-3 to mice. Leukemia 1: 762-764.
145. Hansen, N.E., Malmquist, J., and Thorell, J. 1975. Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics. Acta Med. Scand. 198: 437-443.
146. Harbitz, O., Jensen, A.O., and Smidsrod, O. 1984. Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Eur. J. Res. Dis. 65: 512-520.
147. Harmon, R.J., Schanbacher, F.L., Fergusson, L.C., and Smith, K.L. 1976. Changes in lactoferrin, immunoglobulin G, bovine serum albumin, and alpha-lactalbumin during acute experimental and natural coliform mastitis in cows. Infect. Immun. 13: 533-542.
148. Harmsen, M.C., Swart, P.J., de Bethune, M.P., Pauwels, R., De Clercq, E., The, T.H., and Meijer D.K. 1995. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172: 380-388.
149. Harris, W.R. 1986. Thermodynamics of gallium complexation by human lactoferrin. Biochemistry 25: 803-808.
150. Hasegawa, K., Motsuchi, W., Tanaka, S., and Dosako, S. 1994. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47: 73-85.
151. Hashizume, S., Kuroda, K., and Murakami, H. 1983. Identification of lactoferrin as an essential growth factor for human lymphocytic cell lines m serum-free medium. Biochim. Biophys. Acta 763: 377-382.
152. He, J., and Furmanski, P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721-724.
153. Hekman, A. 1971. Association of lactoferrin with other proteins, as demonstrated by changes in elec-trophoretic mobility. Biochim. Biophys. Acta 251: 380-387.
154. Hentges, D.J., Marsh, W.W., Petschow, B.W., Thai, W.R., and Carter, M.K. 1992. Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J Peel Gastroenterol. Nutr. 14: 146-152.
155. Hirai, Y., Kawakata, N., Satoh, K., Ikeda, Y., Hisayasu, S., Orimo, H., and Yoshino, Y. 1990. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J. Nutr. Sci. Vitaminol. (Tokyo) 36: 531-544.
156. Hoek, K.S., Milne, J.M., Grieve, P.A., Dionysius, D.A., and Smith, R. 1997. Antibacterial activity in bovine lactoferrin-derived peptides. Antimicrob. Agents Chemother. 41: 54-59.
157. Holmgren, J., Svennerholm, A.M., and Ahren, C. 1981. Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglution) and enterotoxin binding of Escherichia coli and Vibrio choler-ae. Infect. Immun. 33: 136-141.
158. Honour, P., and Dolby, J.M. 1979. Bacteriostasis of Escherichia coli by milk. III. The activity and stability of early, transitional and mature human milk collected locally. J. Hyg. (Lond.). 83: 243-254.
159. Hu, W.L., Mazurier, J., Montreuil, J., and Spik, G. 1990. Isolation and partial characterization of a lacto-transferrin receptor from mouse intestinal brush border. Biochemistry 29: 535-541.
160. Husson, M.O., Legrand, D., Spik, G., andLeclerc, H. 1993. Iron acquisition by Helicobacter pylori: importance of human lactoferrin. Infect. Immun. 61: 2694-2697.
161. Hutchens, T.W., Magnuson, J.S., and Yip, T.T. 1989. Rapid purification of porcine colostral whey lactoferrin by affinity chromatography on single-stranded DNA-agarose. Characterization, amino acid composition, and N-terminal aminoacid sequence. Biochim. Biophys. Acta 999: 323-329.
162. Iigo, M., Kuhara, T., Ushida, Y., Sekine, K., Moore, M.A., and Tsuda, H. 1999. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 17: 35-40.
163. Illingworth, D.S., Walter, K.S., Griffiths, P.L., and Barclay, R. 1993. Siderophore production and iron-regulated envelope proteins of Helicobacter pylori. Zentralbl. Bakteriol. 280: 113-119.
164. Isamida, T., Tanaka, T., Omata, Y., Yamauchi, K., Shimazaki, K., and Saito, A. 1998. Protective effect of lactoferricin against Toxoplasma gondii infection in mice. J. Vet. Med. Sci. 60: 241-244.
165. Izhar, M., Nuchamowitz, Y., and Mirelman, D. 1982. Adherence of Shigella flexneri to guinea pig intestinal cells is mediated by a mucosal adhesin. Infect. Immun. 35: 1110-1118.
166. Janssen, P.T., and van Bijsterveld, O.P. 1982. Immunochemical determination of human tear lysozyme (muramidase) in keratoconjunctivitis sicca. Clin. Chim. Acta. 121: 251-260.
167. Janssen, P.T., and van Bijsterveld, O.P. 1983. A simple test for lacrimal gland function: a tear lactoferrin assay by radial immunodiffusion. Gräfes. Arch. Clin. Exp. Opthalmol. 220: 171-174.
168. Jarosik, G.P., Land, C.B., Duhon, P., Chandler, R., and Mercer, T. 1998. Acquisition of iron by Gardnerella vaginalis. Infect. Immun. 66: 5041-5047.
169. Johanson, B. 1960. Isolation of an iron-containing red protein from human milk. Acta Chem. Scand. 14: 510-512.
170. Jolles, J., Donda, A., Amiguet, P., and Jolles, P. 1984. Mare lactotransferrin: purification, analysis and N-terminal sequence determination. FEES Lett. 176: 185-188.
171. Kalfas, S., Andersson, M., Edwardsson, S., Forsgren, A., and Naidu, A.S. 1991. Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia, and Prevotella melaninogenica. Oral Microbiol. Immunol. 6: 350-355.
172. Kalfas, S., Tigyi, Z., Wikstrom, M., and Naidu, A.S. 1992. Laminin binding to Prevotella intermedia. Oral Microbiol. Immunol. 7: 235-239.
173. Kalmar, J.R., and Arnold, RR 1988. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect. Immun. 56: 2552-2557.
174. Kang, J.H., Lee, M.K., Kim, K.L., and Hahm, K.S. 1996. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Pept. Protein Res. 48: 357-363.
175. Kawakami, H., and Lönnerdal, B. 1991. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am. J. Physiol. 26:841-846.
176. Kawasaki, Y., Isoda, H., Shinmoto, H., Tanimoto, M., Dosako, S., Idota, T., and Nakajima, I. 1993. inhibition by kappa-casein glycomacropeptide and lactoferrin of influenza virus hemagglutination. Biosci. Biotechnol. Biochem. 57: 1214-1215.
177. Keen, C.L., Fransson, G.B., and Lönnerdal, B. 1984. Supplementation of milk with iron bound to lactoferrin using weanling mice: II. Effects on tissue manganese, zinc and copper. J. Ped. Gastroenterol. Nutr. 3: 256-261.
178. Kennedy, R.S., Konok, G.P., Bounous, G., Baruchel, S., and Lee, T.D.G. 1995. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma:A phase I-II clinical study. Anticancer Res. 15: 2643-2650.
179. Khin, M.M., Ringner, M., Aleljung, P., Wadstrom, T., and Ho, B. 1996. Binding of human plasminogen and lactoferrin by Helicobacter pylori coccoid forms. J. Med. Microbiol. 45: 433-439.
180. Kijlstra, A.S., Jeurissen, H.M., and Koning, K.M. 1983. Lactoferrin levels in normal human tears. Br. J. Opthalmol. 67: 199-202.
181. Kinkade, J.M., Miller III, W.W.K., and Segars, F.M. 1976. Isolation and characterization of murine lactoferrin. Biochim. Biophys. Acta 446: 407-418.
182. Kioke, D., and Makmo I. 1993. Protective effect of lactoferrin on caerulein-induced acute pancreatitis in rats. Digestion. 54: 84-90.
183. Kirkpatrick, C.H., Green, I., Rich, R.R., and Schade, A.L. 1971. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis. 124: 539-544.
184. Kishore, AR., Erdei, J., Naidu, S.S., Falsen, E., Forsgren, A., Naidu, A.S. 1991. Specific binding of lactoferrin to Aeromonas hydrophila. FEMSMicrobiol. Lett. 67: 115-119.
185. Klasing, K.C. 1984. Effect of inflammatory agents and interleukin 1 on iron and zinc metabolism. Am. J. Physiol. 247: R901-R904.
186. Klebanoff, S.J., and Waltersdorph, A.M. 1990. Prooxidant activity of transferrin and lactoferrin. J. Exp. Med. 172: 1293-1303.
187. Klempner, M.S, Dinarello, C.A., and Gallin, J.I. 1978. Human leukocytic progen induces release of specific granule contents from human neutrophils. J. Clin. Invest. 61: 1330-1336.
188. Koivuranta-Vaara, P., Banda, D., and Goldstein, M. 1987. Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha. Infect. Immun. 55: 2956-61.
189. Kokriakov, V.N., Alishina, G.M., Slepenkov, S.V., Lakovleva, M.F., and Pigarevskii, V.E. 1988. O Stepeni strukturnoi gomologii laktokerrinov moloka i neitrofilʼnykh granulositov. Biokhimiia 53: 1837-1843.
190. Krysteva, M., Mazurier, J., Spik, G., and Montreuil, J. 1975. Comparative study on histidine modification by diethylpyrocarbonate in human serotransferrin and lactotransferrin. FEBS Lett. 56: 337-340.
191. Kulics, J. and Kijlstra, A. 1987. The effect of lactoferrin on complement mediated modulation of immune complex size. Immunol. Lett. 14: 349-353.
192. Kume, S., and Tanabe, S. 1994. Effect of twinning and supplemental iron-saturated lactoferrin on iron status of newborn calves. J. Dairy Sei. 77: 3118-3123.
193. Kume, S., and Tanabe, S. 1995. Effect of supplemental lactoferrin with ferrous iron on iron status of new-bom calves. J. Dairy Sci. 79: 459-464.
194. Lampreave, F., Pineiro, A., Brock, J.H., Castillo, H., Sanchez, L., and Calvo, M. 1990. Interaction of bovine lactoferrin with other proteins of milk whey. Int. J. Biol. Macromol. 12: 2-5.
195. Lash, J.A., Coates, T.D., Lauze, J., Baehner, R.L., and Boxer, L.A. 1983. Plasma lactoferrin reflects granulocyte activation in vivo. Blood 61: 885-888.
196. Lassiter, M.O., Newsome, A.L., Sams, L.D., and Arnold. R.R. 1987. Characterization of lactoferrin interaction with Streptococcus mutans. J. Dent. Res. 66: 480-485.
197. Lassiter, M.O. 1990. Euiylenediaminetetraacetate (EDTA): Influence on the antimicrobial activity of human lactoferrin against Escherichia coli and Streptococcus mutans. Doctoral Thesis. Department of Pathology, School of Medicine. Atlanta, Georgia: Emory University.
198. Leblebicioglu, B., Lim, J.S., Cario, A.C., Beck, F.M., and Walters, J.D. 1996. pH changes observed in the inflamed gingival crevice modulate human polymorphonuclear leukocyte activation in vitro. J. Periodontal. 67: 472-477.
199. Lee, W.J., Farmer, J.L., Hilty, M., and Kim, Y.B. 1998. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect. Immun. 66: 1421-1426.
200. Leffell, M.S., and. Spitznagel, J.K. 1975. Fate of human lactoferrin and myeloperoxidase in phagocytos-ing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex beads. Infect. Immun. 12: 813-820.
201. Li, Y.M., Tan, A.X., and Vlassara, H. 1995. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modilied proteins to a conserved motif. Nat. Med. 1: 1057-1061.
202. Lima, M.F., and Kierszenbaum, F. 1985. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J. Immunol. 134: 4176-4183.
203. Lima, M.F., and Kierszenbaum, F. 1987. Lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. J. Immunol. 139: 1647-1651.
204. Lima, M.F., Beltz, L.A., and Kierszenbaum, F. 1988. Trypanosoma cruzi: a specific surface marker for the amastigote form. J. Protozoal. 35: 108-110.
205. Longhi, C, Conte, M.P., Seganti, L., Polidoro, M., Alfsen, A., and Valenti, P. 1993. Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells. Med. Microbiol. Immunol. 182: 25-35.
206. Lönnerdal, B. 1989. Trace element absorption in infants as a foundation to setting upper limits for trace elements in infant formulas. J. Nutr.(Suppl) 119: 1839-1844.
207. Loughlin, K.R., and Gittes, R.F., Partridge, D., and Stelos, P. 1987. The relationship of lactoferrin to the anemia of renal cell carcinoma. Cancer 59: 566-571.
208. Lu, L., Hangoc, G., Oliff, A., Chen, L.T., Shen, R.N., and Broxmeyer, H.E. 1987. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. Cancer Res. 47: 4184-4188.
209. Lugtenberg, B., and van Alphen, L. 1983. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim. Biophys. Acta 737: 51-115.
210. Luqmani, Y.A., Campbell, T.A., Bennett, C, Coombes, R.C., and Paterson, I.M. 1991. Expression of lactoferrin in human stomach. Int. J. Cancer 49: 684-687.
211. Machnicki, M., Zimecki, M., and Zagulski, T. 1993. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74: 433-439.
212. Malmquist, J., and Johansson, B.G. 1971. Interaction of lactoferrin with agar gels and with trypan blue. Biochim. Biophys. Acta 236: 38-46.
213. Mann, D.M., Romm, E., and Migliorini, M. 1994. Delineation of the glycosaminoglycan binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269: 23661-23667.
214. Marchetti, M., Longhi, C, Conte, M.P., Pisani, S., Valenti, P., and Seganti, L. 1996. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral. Res. 29: 221-231.
215. Mason, D.Y., and Taylor, C.R. 1978. Distribution of transferrin, ferritin, and lactoferrin in human tissues. J. Clin. Pathol. 31: 316-327.
216. Masson, P.L, Carbonara, A.O., and Heremans, J.F. 1965a. Studies on the proteins of human saliva. Biochim. Biophys. Acta 107: 485-500.
217. Masson, P.L., Heremans, J.F., and Prignot, J., 1965b. Immunohistochemical localization of the iron-binding protein lactoferrin in human bronchial glands. Experimentia (Basel) 21: 604-610.
218. Masson, P.L, Carbonara, A.O., and Heremans, J.F. 1965c. Studies on the proteins of human bronchial secretions. Biochim. Biophys. Acta 111: 466.
219. Masson, P.L., Heremans, J.F., Prignot, J.J., and Wauters, G. 1966. Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax 21: 538-544.
220. Masson, P.L., Heremans, J.F., and Schonne, E. 1969. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658.
221. Masson, P.L., and Heremans, J.F. 1968. Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction. Eur J Biochem. 6: 579-584.
222. Masson, P.L., and Heremans, J.F. 1971. Lactoferrin in milk from different species. Comp. Biochem. Physiol 39B:119-129.
223. Mattsby-Baltzer, I., Roseanu, A., Motas, C, Elverfors, J., Engberg, I., and Hanson, L.A. 1996. Lactoferrin or a fragment thereof inhibits the endotoxin-induced mterleukin-6 response in human monocytic cells. Pediatr. Res. 40: 257-262.
224. Mazurier, J., and Spik, G. 1980. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629: 399-407.
225. Mazurier, J., Léger, D., Tordera, V., Montreuil, J., and Spik, G. 1981. Comparative study of the iron-binding properties of transferrins: Differences in the involvement of histidine residues as revealed by car-bethoxylation. Eur. J. Biochem. 119: 537-543.
226. McCormick, J.A., Markey, G.M., and Morris, T.C.M. 1991. Lactoferrin-inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity. Clin. Exp.Immunol 83: 154-156.
227. McMillan, J.A., Oski, F.A., Lourie, G., Tomarelli, R.M., and Landaw, S.A. 1977. Iron absorption from human milk, simulated human milk, and proprietary formulas. Pediatrics 60: 896-900.
228. Menozzi, F.D., Ganteiz, C, and Locht, C. 1991. Identification and purification of transferrin and lactofer-rin-binding proteins of Bordetella pertussis and Bordetella bronchoseptica. Infect. Immun. 59: 3982-3988.
229. Metz-Boutigue, M.H., Jolies, J., Mazurier, J., Schoentgen, F., Legrand, D., Spik, G., Montreuil, J., and Jolies, P. 1984. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145: 659-676.
230. Mickelsen, P.A., Blackmail, E., and Sparling, P.F. 1982. Ability of Neisseria gonorrhoeae, Neisseria meningitidis and commensal Neisseria species to obtain iron from lactoferrin. Infect. Immun. 35: 915-920.
231. Miedzobrodzki, J., Naidu, A.S., Watts, J.L., Ciborowski, P., Palm, K., and Wadstrom, T. 1989. Effect of milk on fibronectin and collagen type-I binding to Staphylcoccus aureus and coagulase-negative staphylococci isolated from bovine mastitis. J. Clin. Microbiol. 27: 540-544.
232. Miyauchi, H., Kaino, A., Shinoda, I., Fukuwatari, Y., and Hayasawa, H. 1997. Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer’s patch cells. J. Dairy Sci. 80: 2330-2339.
233. Miyazawa, K., Mantel, C, Lu, L., Morrison, D.C., and Broxmeyer, H.E. 1991. Lactoferrin-lipopolysac-charide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells. J. Immunol. 146: 723-729.
234. Moguilevsky, N., Retegui, L.A., and Masson, P.L. 1985. Comparison of human lactoferrins from milk and neutrophilic leukocytes: relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem. J. 229: 353-359.
235. Montreuil, J., Tonnelat, J., and Mullet, S. 1960. Preparation and properties of lactoferrin of human milk. Biochim. Biophys. Acta 45: 413-421.
236. Moore, S.A., Anderson, B.F., Groom, C.R., Haridas, M., and Baker, E.N. 1997. Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution. J. Mol. Biol. 274: 222-236.
237. Muller, F., Holberg-Petersen, M., Rollag, H., Degré, M., Brandtzaeg, P., and Froland, S.S. 1992. Nonspecific oral immunity in individuals with HIV infection. J. Acquir. Immune Defic. Syndr. 5: 46-51.
238. Naidu, A.S., Miedzobrodzki, J., Andersson, M., Nilsson, L.E., Forsgren, A., and Watts, J.L. 1990. Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections. J. Clin. Microbiol. 28: 2312-2319.
239. Naidu, A.S., Miedzobrodzki, J., Musser, J.M., Rosdahl, V.T., Hedstrom, S.A., and Forsgren, A. 1991a. Human lactoferrin binding in clinical isolates of Staphylococcus aureus. J. Med. Microbiol. 34: 323-328.
240. Naidu, S.S., Erdei, J., Czirok, E., Kalfas, S., Gado, I., Thoren, A., Forsgren, A., and Naidu, A.S. 1991b. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections. APMIS. 99: 1142-1150.
241. Naidu, A.S., Andersson, M., and Forsgren, A. 1992. Identification of a human lactoferrin-binding protein in Staphylococcus aureus. J. Med. Microbiol. 36: 177-183.
242. Naidu, S.S., Svensson, U., Kishore, A.R., and Naidu, A.S. 1993. Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium. Antimicrob. Agents Chemother. 37: 240-245.
243. Naidu, A.S., and Arnold, R.R. 1994. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility in vitro. Diagn. Microbiol. Infect. Dis. 20: 69-75.
244. Naidu, A.S. and Arnold, R.R. 1997. Influence of lactoferrin on host-microbe interactions. In Lactoferrin-Interactions and Biological Functions, ed. T.W. Hutchens, and B. Lonnerdal, 259-275. Totowa, NJ: Humana Press.
245. Naidu, A.S., and Bidlack, W.R. 1998. Milk lactoferrin-Natural microbial blocking agent (MBA) for food safety. Environ. Nutr. Interact. 2: 35-50.
246. Nichols, B.L., McKee, K.S., and Huebers, H.A. 1990. Iron is not required in the lactoferrin stimulation of thymidine incorporation into the DNA of rat crypt enterocytes. Pediatr. Res. 27: 525-528.
247. Nicholson, H., Anderson, B.F., Bland, T., Shewry, S.C., Tweedie, J.W., and Baker, E.N. 1997. Mutagenesis of the histidine ligand in human lactoferrin: iron binding properties and crystal structure of the histidine-253 methionine mutant. Biochemistry 36: 341-346.
248. Nikaido, H., and Vaara, M. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49: 1-31.
249. Nikaido, H. 1989. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33: 1831-1836.
250. Nishiya, K. and Horwitz, P.A. 1982. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer cell activity and antibody-dependent cell mediated cytotoxicity. J. Immunol. 129: 2519-2523.
251. Nonnecke, B.J., and Smith, K.L. 1984a. Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth. J. Dairy Sci. 67: 606-613.
252. Nonnecke, B.J., and Smith, K.L. 1984b. Biochemical and antibacterial properties of bovine mammary secretion during mammary involution and at parturition. J. Dairy Sci. 67: 2863-2872.
253. Norris, G.E., Andersson, B.F., Baker, E.N., Baker, H.M., Gartner, A.L., Ward, J., and Rumball, S.V. 1986. Preliminary crystallographic studies on bovine lactoferrin. J. Mol. Biol. 191: 143-145.
254. Odell, E.W., Sarra, R, Foxworthy, M., Chappie, D.S., and Evans, R.W. 1996. Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett. 382: 175-178.
255. Okujo, N., Akiyama, T., Miyoshi, S., Shinoda, S., and Yamamoto, S. 1996. Involvement of vulnibactin and exocellular protease in utilization of transferrin-and lactoferrin-bound iron by Vibrio vulnificus. Microbiol. Immunol. 40: 595-598.
256. Okutomi, T., Tanaka, T., Yui, S., Mikami, M., Yamazaki, M., Abe, S., and Yamaguchi, H. 1998. Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin. Microbiol. Immunol. 42: 789-793.
257. Olofson, T., Olsson, I., Venge, P., and Elgefors, B. 1977. Serum myeloperoxidase and lactoferrin in neutropenia. Scand. J. Haematol. 18: 73-80.
258. Olusanya, O., and Naidu, A.S. 1991. Influence of mucin on serum and connective tissue protein binding to Staphylococcus aureus isolated from nasal carriage and cluneal sources. Afr. J. Med. Sci. 20: 89-95.
259. Oram, J.D. and Reiter, B. 1968. Inhibition of bacteria by lactoferrin and other iron-chelating agents. Biochim. Biophys. Acta 170: 351-365.
260. Osbome, T.B., and Campbell, G.F. 1900. The protein constituents of egg white. J. Am. Chern. Soc. 22: 422-426.
261. Oseas, R., Yang, H.H., Baehner, R.L., and Boxer, L.A. 1981. Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness. Blood 57: 939-945.
262. Otto, B.R., Verweij-van Vught, A.M., and MacLaren, D.M. 1992. Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit. Rev. Microbiol. 18: 217-233.
263. Palma, C, Serbousek, D., Torosantucci, A., Cassone, A., and Djeu, J.Y. 1992. Identification of a manno-protein fraction from Candida albicans that enhances human polymorphonuclear leukocyte (PMNL) functions and stimulates lactoferrin in PMNL inhibition of candidal growth. J. Infect. Dis. 166: 1103-1112.
264. Paulsson, M.A., Svensson, U., Kishore, A.R., and Naidu, A.S. 1993. Thermal behavior of bovine lactoferrin in water and its relation to bacterial interaction and antibacterial activity. J. Dairy Sci. 76: 3711-3720.
265. Payne, K.D., Davidson, P.M., Oliver, S.P., and Christian, G.L. 1990. Influence of bovine lactoferrin on tire growth of Listeria monocytogenes. J. Food Prot. 53: 468-472.
266. Payne, K.D., Davidson, P.M., and Oliver, S.P. 1994. Comparison of EDTA and apo-lactoferrin with lysozyme on the growth of food-borne pathogenic and spoilage bacteria. J. Food Prot. 57: 62-65.
267. Pelus, L.M., Broxmeyer, H.E., and Moore, M.A. 1981. Regulation of human myelopoiesis by prostaglandin E and lactoferrin. Cell Tissue Kinet. 14: 515-526.
268. Pentecost, B.T., and Teng, C.T. 1987. Lactotransferrin is the major estrogen inducible protein of mouse uterine secretions. J. Biol. Chem. 262: 10134-10139.
269. Perraudin, J.P., Prieels, J.P., and Leonis, J. 1974. Interaction between lysozyme and some lactoferrin complex in human milk. Arch. Int. Physiol. Biochim. 82: 1001.
270. Peterson, K.M., and Alderete, J.F. 1984. Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J. Exp Med. 160: 398-410.
271. Pettersson, A., Maas, A., and Tommassen, J. 1994. Identification of the iroA gene product of Neisseria meningitidis as a lactoferrin receptor. J. Bacterial. 176: 1764-1766.
272. Querinjean, P., Masson, P.L., and Heremans, J.F. 1971. Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur. J. Biochem. 20: 420-425.
273. Rainard, P. 1986a. Bacteriostasis of Escherichia coli by bovine lactoferrin, transferrin and immunoglobulins (IgGl, IgG2, IgM) acting alone or in combination. Vet. Microbiol. 11: 103-115.
274. Rainard, P. 1986b. Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet. Microbiol. 11: 387-392.
275. Rainard, P. 1987. Bacteriostatic activity of bovine lactoferrin in mastitic milk. Vet. Microbiol. 13: 159-166.
276. Rainard, P. 1992. Binding of bovine lactoferrin to Streptococcus agalactiae. FEMS Microbiol. Lett. 77: 235-239.
277. Rainard, P. 1993. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology’ 79: 648-652.
278. Raphael, G.D., Jeney, E.V., Baranuik, J.N., Kim, I., Meridith, S.D., and Kaliner, M.A. 1989. Pathophysiology of rhinitis: lactoferrin and lysozyme in nasal secretion. J. Clin. Invest. 84: 1528-1535.
279. Regoeczi, E., Chindemi, P.A., Debanne, M.T., and Prieels, J.P. 1985. Lactoferrin catabolism in the rat liver. Am.J. Physiol. 248: G8-G14.
280. Regoeczi, E., Chindemi, P.A., and Hu, W.L. 1994. Transport of lactoferrin from blood to bile in the rat. Hepatology 19: 1476-1482.
281. Reiter, B., and Oram, J.D. 1967. Bacterial inhibitors in milk and other biological fluids. Nature 216: 328-330.
282. Reiter, B., Brock, J.H., and Steel, E.D. 1975. Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli. Immunology 28: 83-95.
283. Rejman, J.J., Hegarty, H.M., and Hurley, W.L. 1989. Purification and characterization of bovine lactoferrin from secretions of the involuting mammary gland: Identification of multiple molecular forms. Comp. Biochem. Physiol. 93B:929-934.
284. Roberts, A.K., Chierici, R., Hill, M.J., Volpata, S., and Vigi, V. 1992. Supplementation of an adapted formula with bovine lactoferrin: I. Effect on the infant fecal flora. Acta Paediatr. 81: 119-124.
285. Rogers, H.J., and Synge, C. 1978. Bacteriostatic effect of human milk on Escherichia coir, the role of IgA. Immunology 34: 19-28.
286. Rogers, T.B., Borresen, T., and Feeney, R.E. 1978. Chemical modification of the arginines in transferrins. Biochemistry 17: 1105-1109.
287. Rosa, G., and Trugo, N.M. 1994. Iron uptake from lactoferrin by intestinal brush-border membrane vesicles of human neonates. Bra:. J. Med. Biol. Res. 27: 1527-1531.
288. Rumke, P., Visser, D., Kwa, H.G., and Hart, A.A.M. 1971. Radioimmunoassay for lactoferrin in blood plasma of breast cancer patients, lactating, and normal women: prevention of false high levels caused by leakage from neutrophil leukocytes in vitro. Folia Med. Netherland. 14: 156-168.
289. Rumke, P. 1974. The origin of immunoglobulins in semen. Clin. Exp. Med. 14: 1068-1084.
290. Saito, H., Takase, M., Tamura, Y., Shimamura, S., and Tomita, M. 1994. Physicochemical and antibacterial properties of lactoferrin and its hydrolysate produced by heat treatment at acidic pH. Adv. Exp. Med. Biol. 357: 219-226.
291. Salamah, A.A., and al-Obaidi, A.S. 1995a. In vivo and in vitro effects of lactoferrin on Yersinia pseudotuberculosis. New Microbiol 18: 267-274.
292. Salamah, A.A., and al-Obaidi, A.S. 1995b. Effect of some physical and chemical factors on the bactericidal activity of human lactoferrin and transferrin against Yersinia pseudotuberculosis. New Microbiol 18: 275-281.
293. Samaranayake, Y.H., Samaranayake, L.P., Wu, P.C., and So, M. 1997. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. APMIS 105: 875-883.
294. Sanchez, L., Ismail, M., Liew, F.Y., and Brock, J.H. 1996. Iron transport across Caco-2 cell monolayers. Effect of transferrin, lactoferrin and nitric oxide. Biochim. Biophys. Acta 1289: 291-297.
295. Sato, N., Kurotaki, H., Ikeda, S., Daio, R., Nishinome, N., Mikami, T., and Matsumoto, T. 1999. Lactoferrin inhibits Bacillus cereus growth and heme analogs recover its growth. Biol Pharm. Bull. 22: 197-199.
296. Sato, R., Inanami, O., Tanaka, Y., Takase, M., and Naito, Y. 1996. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FlV)-positive and FlV-neg-ative cats. Am. J. Vet. Res. 57: 1443-1446.
297. Sawatzki, G., and Rich, I.N. 1989. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15: 371-385.
298. Schade, A.L., and Caroline, L. 1946. An iron-binding component in human blood plasma. Science 104: 340.
299. Schafer, K.H. 1951. Elekrophoretische untersuchungen zum milcheiweissproblem. Montssschrift fur Kindrheilkunde 99: 69-71.
300. Schlabach, M.R. and Bates, G.W. 1975. The synergistic binding of anions and Fe(III) by transferrin. Implications for the interlocking sites hypothesis. J. Biol. Chem. 250: 2182-2188.
301. Schryver, A.B., and Morris, L.J. 1988. Identification and characterization of the transferrin receptor from Neisseria meningitidis. Mol. Microbiol. 2: 281-288.
302. Schryver, A.B. 1989. Identification of the transferrin-and lactoferrin-binding proteins in Haemophilus influenzae. J. Med. Microbiol. 29: 121-130.
303. Schryver, A.B., and Stojiljkovic, I. 1999. Iron acquisition systems in the pathogenic Neisseria. Mol. Microbiol. 32: 1117-1123.
304. Schulz-Lell, G., Dorner, K., Oldigs, H.D., Sievers, E., and Schaub, J. 1991. Iron availability from an infant formula supplemented with bovine lactoferrin. Acta Paediatr. Scand. 80: 155-158.
305. Sekine, K., Watanabe, E., Nakamura, J., Takasuka, N., Kim, D.J., Asamoto, M., Krutovskikh, V., Baba-Toriyama, FL, Ota, T., Moore, M.A., Masuda, M., Sugimoto, FL, Nishino, H., Kakizoe, T., and Tsuda, H. 1997a. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Jpn. J. Cancer Res. 88: 523-526.
306. Sekine, K., Ushida, Y., Kuhara, T., Iigo, M., Baba-Toriyama, H., Moore, M.A., Murakoshi, M., Satomi, Y., Nishino, FL, Kakizoe, T., and Tsuda, H. 1997b. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Lett. 121: 211-216.
307. Shau, H., Kim, A., Golub, S.H. 1992. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol. 51: 343-349.
308. Shimazaki, K., and Nishio, N. 1991. Interacting properties of bovine lactoferrin with immobilized Cibacron blue F3GA in column chromatography. J. Dairy Sci. 74: 404-408.
309. Shimazaki, K., Kawaguchi, A., Sato, T., Ueda, Y., Tommimura, T., and Shimamura, S. 1993. Analysis of human and bovine milk lactoferrins by rotafor and chromatofocusing. Int. J. Biochem. 25: 1653-1658.
310. Shimazaki, K., Nam, M.S., Harakawa, S., Tanaka, T., Omata, Y., Saito, A., Kumura, FL, Mikawa, K., Igarashi, I., and Suzuki, N. 1996. Monoclonal antibody against bovine lactoferricin and its epitopic site. J. Vet. Med. Sci. 58: 1227-1229.
311. Shimizu, K., Matsuzawa, FL, Okada, K., Tazume, S., Dosako, S., Kawasaki, Y., Hashimoto, K., and Koga, Y. 1996. Lactoferrin-mediated protection of tire host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol. 141: 1875-1889.
312. Shin, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., Tomita, M., Otsuka, Y., Yamazaki, S. 1998. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli 0157:H7. Lett. Appl. Microbiol. 26: 407-411.
313. Shinmoto, H., Kobori, M., Tsushida, T., and Shinohara, K. 1997. Competitive ELISA of bovine lactoferrin with bispecific monoclonal antibodies. Biosci. Biotechnol. Biochem. 61: 1044-1046.
314. Smith, K.L., Conrad, H.R., and Porter, R.M. 1971. Lactoferrin and IgG immunoglobulins from involuted bovine mammary glands. J Dairy Sci. 54: 1427-1435.
315. Sojar, H.T., Hamada, N. and Genco, R.J. 1998. Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin. FEBS Lett. 422: 205-208.
316. Sorensen, M., and Sorensen, S.P.L. 1939. The proteins in whey. CR. Trav. Lab. Carlsberg. 23: 55-99.
317. Soukka, T., Lumikari, M., and Tenovuo, J. 1991. Combined inhibitory effect of lactoferrin and lactoper-oxidase system on the viability of Streptococcus mutatis, serotype c. Scand. J. Dent. Res. 99: 390-396.
318. Spik, G., Bayard, B., Fournet, B., Stacker, G., Bouquelet, S., and Montreuil, J. 1975. Studies on glyco-conjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett. 50: 296-299.
319. Spik, G., Stacker, G., Fournet, B., Bouquelet, S., Montreuil, J., Dorland, L., Van Halbeek, H., and Vliegenthart, J.F.G. 1982. Primary structure of glycans from human lactotransferrin. Eur. J. Biochem. 121: 413-419.
320. Staggs, T.M., Greer, M.K., Baseman, J.B., Holt, S.C., and Tyron, V.V. 1994. Identification of lactoferrin-binding proteins from Treponema pallidum subspecies pallidum and Treponema denticola. Mol. Microbiol. 12: 613-619.
321. Stuart, J., Norrell, S., and Harrington, J.P. 1984. Kinetic effect of human lactoferrin on the growth of Escherichia coli Oil 1. Int. J. Biochem. 16: 1043-1047.
322. Superti, F., Ammendolia, M.G., Valenti, P., and Seganti, L. 1997. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. (Bed.) 186: 83.
323. Swart, P.J., Kuipers, M.E., Smit, C, Pauwels, R., deBethune, M.P., de Clercq, E., Meijer, D.K., and Huisman, J.G. 1996. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res. Hum. Retroviruses. 12:769-775.
324. Szuchet-Derechin, S., and Johnson, P. 1965. The ‘Albumin’ fraction of bovine milk-II. The isolation and physicochemical properties of the red proteins. Eur. Polymer J. 1: 283-291.
325. Tabak, L., Mandel, I.D., Herrera, M., and Baurmash, H. 1978. Changes in lactoferrin and other proteins in a case of chronic recurrent parotitis. J. Oral Path. 1: 97-99.
326. Tachezy, J., Kulda, J., Bahnikova, I., Suchan, P., Razga, J., and Schrevel, J. 1996. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin. Exp. Parasitol. 83: 216-228.
327. Tanaka, T., Omata, Y., Saito, A., Shimazaki, K., Igarashi, I., and Suzuki, N. 1996. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells. J. Vet. Med. Sei. 58: 61-65.
328. Tashima, K.T., Carroll, P.A., Rogers, M.B., and Calderwood, S.B. 1996. Relative importance of three iron-regulated outer membrane proteins for in vivo growth of Vibrio cholerae. Infect. Immun. 64: 1756-1761.
329. Teng, C. T., Walker, M. P., Bhattacharyya, S. N., Klapper, D. G., DiAugustine, R. P., and McLachlan, J. A. 1986. Purification and properties of an oestrogen-stimulated mouse uterine glycoprotein (approx. 70 kDa). Biochem. J. 240: 413-422.
330. Teraguchi, S., Shin, K., Ozawa, K., Nakamura, S., Fukuwatari, Y., Tsuyuki, S., Narnihira, H., and Shimamura, S. 1995a. Bacteriostatic effect of orally administered bovine lactoferrin on proliferation of Clostridium species in the gut of mice fed bovine milk. Appl. Environ. Microbiol. 61: 501-506.
331. Teraguchi, S., Silin, K., Ogata, T., Kingaku, M., Kaino, A., Miyauchi, H., Fukuwatari, Y., and Shimamura, S. 1995b. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk. Appl. Environ. Microbiol. 61: 4131-4134.
332. Teraguchi, S., Shin, K., Fukuwatari, Y., and Shimamura, S. 1996. Glycans of bovine lactoferrin function as receptors for the type 1 fimbrial lectin of Escherichia coli. Infect. Immun. 64: 1075-1077.
333. Teuwissen, B., Masson, P.L., Osinski, P., and Heremans, J.F. 1972. Metal-combining properties of human lactoferrin. The possible involvement of tyrosyl residues in the binding sites. Spectrophotometric titration. Eur. J. Biochem. 31: 239-245.
334. Thomas, A.S., and Fell, L.R. 1985. Effect of ACTH and oxytocin treatment on lactoferrin and citrate in cows’ milk. J. Dairy Res. 52: 379-389.
335. Tigyi, Z., Kishore, A.R, Maeland, J.A., Forsgren, A., and Naidu, A.S. 1992. Lactoferrin-binding proteins in Shigella flexneri. Infect. Immun. 60: 2619-2626.
336. Todhunter, D.A., Smith, K.L., and Schoenberger, P.S. 1985. In vitro growth of mastitis-associated streptococci in bovine mammary secretions. J. Dairy Sei. 68: 2337-2346.
337. Torna, C, Honma, Y., and Iwanaga, M. 1996. Effect of Vibrio cholerae non-Ol protease on lysozyme, lactoferrin and secretory immunoglobulin A. FEMS Microbiol. Lett. 135: 143-147.
338. Tomita, M., Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., and Kawase, K. 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sei. 74: 4137-4142.
339. Tomita, M., Takase, M., Wakabayashi, H., and Bellamy, W. 1994. Antimicrobial peptides of lactoferrin. Adv. Exp. Med. Biol. 357: 209-218.
340. Tomita, S., Shirasaki, N., Hayashizaki, H., Matsuyama, J., Benno, Y., and Kiyosawa, I. 1998. Binding characteristics of bovine lactoferrin to the cell surface of Clostridium species and identification of the lactoferrin-binding protein. Biosci. Biotechnol. Biochem. 62: 1476-1482.
341. Tourville, D.R., S.S. Ogra, J. Lippes, and T.B. Tomassi Jr. 1970. The human female reproductive tract:immunohistological localization of gammaA, gammaG, gammaM “secretory piece” and lactoferrin. Am. J. Obstet. Gynecol. 108:1102-342.
342. Trumpler, U., Straub, P.W., and Rosenmund, A. 1989. Antibacterial prophylaxis with lactoferrin in neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 8: 310-313.
343. Tryon, V.V., and Baseman, J.B. 1987. The acquisition of human lactoferrin by Mycoplasma pneumoniae. Microb. Pathog. 3: 437-443.
344. Tsuji, S., Y. Hirata, and K. Matsuoka. 1989. Two apparent molecular forms of bovine lactoferrin. J. Dairy Sci. 72: 1130-1136.
345. Tuccari, G., and G. Barresi. 1985. Immtmohistochemical demonstration of lactoferrin in follicular adenomas and thyroid carcinomas. Virchows Arch. A. 406: 67-74.
346. Tuccari, G., Barresi, G., Arena, F., and Inferrerà, C. 1989. Immunocytochemical detection of lactoferrin in human gastric carcinomas and adenomas. Arch. Pathol. Lab. Med. 113: 912-915.
347. Turchany, J.M., Aley, S.B., and Gillin, F.D. 1995. Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun. 63: 4550-4552.
348. van Berkel, P.H., Geerts, M.E., van Veen, H.A., Mericskay, M., de Boer, H.A., andNuijens, J.H. 1997. N-terminal stretch Arg2, Argi, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 15: 145-451.
349. Van Halbeck, H., Dorland, L., Vliegenthar, J.F.G., Spil, G., Cheron, A., and Montreuil, J. 1981. Structure determination of two oligomannoside-type glycopeptides obtained from bovine lactotransferrin, by 500 MHz 1H-NMR spectroscopy. Biochim. Biophys. Acta 675: 293-296.
350. Van Snick, J., Masson, P.L., and Heremans, J.F. 1974. The involvement of lactoferrin in tire hyposideremia of acute inflammation. J. Exp. Med. 140: 1068-1084.
351. Van Snick, J., and Masson, P.L. 1976. The binding of human lactoferrin to mouse peritoneal cells. J. Exp. Med. 144: 1568-1580.
352. Visca, P., Berlutti, F., Vittorioso, P., Dalmastri, C., Thaller, M.C., and Valenti, P. 1989. Growth and adsorption of Streptococcus mutans 6715-13 to hydroxyapatite in the presence of lactoferrin. Med. Microbiol. Immunol. (Bed) 178: 69-79.
353. Visca, P., Dalmastri, C, Verzili, D., Antonini, G., Chiancone, E., Valenti, P. 1990. Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med. Microbiol. Immunol. (Bed) 179: 323-333.
354. Wada, T., Aiba, Y., Shimizu, K., Takagi, A., Miwa, T., and Koga, Y. 1999. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand. J. Gastroenterol. 34: 238-243.
355. Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., and Yamaguchi, H. 1996. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40: 821-825.
356. Wang, C.S., Chan, W.Y., and Kloer, U.H. 1984. Comparative studies on the chemical and immunochemical properties of human milk, human pancreatic juice and bovine milk lactoferrin. Comp. Biochem. Physiol. (B) 78: 575-580.
357. Wang, D., Pabst, K.M., Aida, Y., and Pabst, MJ. 1995. Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin. J. Leukoc. Biol. 57: 865-874.
358. Watanabe, T., Nagura, H., Watanabe, K., and Brown, W.R. 1984. The binding of human milk lactoferrin to immunoglobulin A. FEBS Lett. 168: 203-207.
359. Weinberg, E.D. 1975. Nutritional immunity. Host’s attempt to withold iron from microbial invaders. JAMA. 231 (1): 39-41.
360. Wichmann, L., Vaalasti, A., Vaalasti, T., and Tuohimaa, P. 1989. Localization of lactoferrin in the male reproductive tract. Int. J. Andrai. 12: 179-186.
361. Williams, P.H., and Carbonetti, N.H. 1986. Iron, siderophores, and the pursuit of virulence: independence of the aerobactin and enterochelin iron uptake systems in Escherichia coli. Infect. Immun. 51: 942-947.
362. Wilson, M.E., Vorhies, R.W., Andersen, K.A., and Britigan, B.E. 1994. Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect. Immun. 62: 3262-3269.
363. Windle, J.J., Wiersema, A.K., Clark, J.R, and Feeney, R.E. 1963. Biochemistry 2:1341-1346.
364. Wu, H.F., Monroe, D.M., and Church, F.C. 1995. Characterization of the glycosaminoglycan binding region of lactoferrin. Arch. Biochem. Biophys. 317: 85-92.
365. Yamauchi, K., Tornita, M., Giehl, T.J., and Ellison, RT. 1993. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61: 719-728.
366. Yamauchi, K., Wakabayashi, H., Hashimoto, S., Teraguchi, S., Hayasawa, H., and Tornita, M. 1998. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv. Exp. Med. Biol. 443: 261-265.
367. Yang, H., Kooi, CD., and Sokol, P.A. 1993. Ability of Pseudomonaspseudomallei malleobactin to acquire transferrin-bound, lactoferrm-bound, and cell-derived iron. Infect. Immun. 61: 656-662.
368. Yi, M., Kaneko, S., Yu, D.Y., and Murakami, S. 1997. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71: 5997-6002.
369. Yoo, Y.C., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., and Azuma, I. 1997. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis m mice. Jpn. J. Cancer Res. 88: 184-190.
370. Yoshida, S. 1989. Preparation of lactoferrin by hydrophobic interaction chromatography from milk acid whey. J. Dairy Sei. 72: 1446-1450.
371. Yoshida, S., and Ye-Xiuyun. 1991. Isolation of lactoperoxidase and lactoferrins from bovine milk acid whey by carboxymethyl cation exchange chromatography. J. Dairy Sei. 74: 1439-1444.
372. Zagulski, T., Lipinski, P., Zagulska, A., Broniek, S., and Jarzabek, Z. 1989. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70: 697-704.
373. Zhao, X.Y., and Hutchens, T.W. 1994. Proposed mechanisms for the involvement of lactoferrin in the hydrolysis of nucleic acids. Adv. Exp. Med. Biol. 357: 271-278.
374. Ziere, GJ., van Dijk, M.C., Bijsterbosch, M.K., and van Berkel, T.J. 1992. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J. Biol. Chem. 267: 11229-11235.
375. Zimecki, M., Mazurier, J., Machnicki, M., Wieczorek, Z., Montreuil, J., and Spik.G. 1991. Immunostimulatory activity of lactotransferrin and maturation of CD4-and CD8-murine thymocytes. Immunol. Lett. 30: 119-124.
376. Zimecki, M., and Machnicki, M. 1994. Lactoferrin inhibits the effector phase of tire delayed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG). Arch. Immunol. Ther. Exp. (Warsz). 42: 171-177.
377. Zimecki, M., Miedzybrodzki, R., and Szymaniec, S. 1998a. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch. Immunol. Ther. Exp. (Warsz) 46: 361-365.
378. Zimecki, M., Wlaszczyk, A., Cheneau, P., Brunei, A.S., Mazurier, J., Spik, G., and Kubier, A. 1998b. Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals. Arch. Immunol. Ther. Exp. (Warsz) 46: 231-240.
379. Zimecki, M., Wlaszczyk, A., Zagulski, T., and Kubier, A. 1998c. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery. Arch. Immunol. Ther. Exp. (Warsz) 46: 97-104.